200 related articles for article (PubMed ID: 21787230)
21. Comparative study using Raman microspectroscopy reveals spectral signatures of human induced pluripotent cells more closely resemble those from human embryonic stem cells than those from differentiated cells.
Tan Y; Konorov SO; Schulze HG; Piret JM; Blades MW; Turner RF
Analyst; 2012 Oct; 137(19):4509-15. PubMed ID: 22888493
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
24. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
25. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells.
Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064
[TBL] [Abstract][Full Text] [Related]
26. Pluripotent stem cells derived from mouse primordial germ cells by small molecule compounds.
Kimura T; Kaga Y; Sekita Y; Fujikawa K; Nakatani T; Odamoto M; Funaki S; Ikawa M; Abe K; Nakano T
Stem Cells; 2015 Jan; 33(1):45-55. PubMed ID: 25186651
[TBL] [Abstract][Full Text] [Related]
27. Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45.
Ke Q; Li L; Yao X; Lai X; Cai B; Chen H; Chen R; Zhai Z; Huang L; Li K; Hu A; Mao FF; Xiang AP; Tao L; Li W
Sci Rep; 2017 Mar; 7(1):458. PubMed ID: 28352086
[TBL] [Abstract][Full Text] [Related]
28. Conversion of genomic imprinting by reprogramming and redifferentiation.
Kim MJ; Choi HW; Jang HJ; Chung HM; Arauzo-Bravo MJ; Schöler HR; Do JT
J Cell Sci; 2013 Jun; 126(Pt 11):2516-24. PubMed ID: 23525019
[TBL] [Abstract][Full Text] [Related]
29. Proteomic identification of RREB1, PDE6B, and CD209 up-regulated in primitive gut tube differentiated from human embryonic stem cells.
Lee DH; Ko JJ; Ji YG; Chung HM; Hwang T
Pancreas; 2012 Jan; 41(1):65-73. PubMed ID: 21792086
[TBL] [Abstract][Full Text] [Related]
30. Comparative Metabolomic Profiling of Rat Embryonic and Induced Pluripotent Stem Cells.
Sherstyuk VV; Yanshole LV; Zelentsova EA; Melnikov AD; Medvedev SP; Tsentalovich YP; Zakian SM
Stem Cell Rev Rep; 2020 Dec; 16(6):1256-1265. PubMed ID: 33047280
[TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
Rezanejad H; Matin MM
Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
[TBL] [Abstract][Full Text] [Related]
32. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
Takayama N; Eto K
Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
[TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of reprogrammed sheep induced pluripotent stem cells.
Liu J; Balehosur D; Murray B; Kelly JM; Sumer H; Verma PJ
Theriogenology; 2012 Jan; 77(2):338-46.e1. PubMed ID: 21958637
[TBL] [Abstract][Full Text] [Related]
34. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
[TBL] [Abstract][Full Text] [Related]
35. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs.
Choi J; Lee S; Mallard W; Clement K; Tagliazucchi GM; Lim H; Choi IY; Ferrari F; Tsankov AM; Pop R; Lee G; Rinn JL; Meissner A; Park PJ; Hochedlinger K
Nat Biotechnol; 2015 Nov; 33(11):1173-81. PubMed ID: 26501951
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive proteogenomic analysis of human embryonic and induced pluripotent stem cells.
Parrotta EI; Scalise S; Taverna D; De Angelis MT; Sarro G; Gaspari M; Santamaria G; Cuda G
J Cell Mol Med; 2019 Aug; 23(8):5440-5453. PubMed ID: 31237115
[TBL] [Abstract][Full Text] [Related]
37. Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.
Benevento M; Munoz J
Expert Rev Proteomics; 2012 Aug; 9(4):379-99. PubMed ID: 22967076
[TBL] [Abstract][Full Text] [Related]
38. Generation of induced pluripotent stem cells (iPSCs) from human foreskin fibroblasts.
Erdlenbruch F; Rohwedel J; Ralfs P; Thomitzek A; Kramer J; Cakiroglu F
Stem Cell Res; 2018 Dec; 33():79-82. PubMed ID: 30321832
[TBL] [Abstract][Full Text] [Related]
39. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells.
Munoz J; Low TY; Kok YJ; Chin A; Frese CK; Ding V; Choo A; Heck AJ
Mol Syst Biol; 2011 Nov; 7():550. PubMed ID: 22108792
[TBL] [Abstract][Full Text] [Related]
40. Who Will Win: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells for β Cell Replacement and Diabetes Disease Modeling?
Jacobson EF; Tzanakakis ES
Curr Diab Rep; 2018 Oct; 18(12):133. PubMed ID: 30343423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
